Integra LifeSciences Holdings Corporation

353 articles with Integra LifeSciences Holdings Corporation

• Integra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance

  2/22/2023

  Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2022, consistent with its preliminary financial results announced on January 10, 2023 and January 25, 2023.       

• Integra LifeSciences to Host Fourth Quarter 2022 Financial Results Conference Call on February 22, 2023

  2/9/2023

  Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, will release fourth quarter 2022 financial results on Wednesday, February 22, 2023, prior to the market open.

• Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials

  1/10/2023

  Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary fourth quarter and full-year 2022 financial results.

• Integra LifeSciences to Present at 41st Annual J.P. Morgan Healthcare Conference

  12/21/2022

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that Jan De Witte, president and chief executive officer will present at the 41st Annual J.P. Morgan Healthcare conference on January 11, 2023 at 7:30pm ET.

• Integra LifeSciences Completes the Acquisition of Surgical Innovation Associates

  12/6/2022

  Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Surgical Innovation Associates (SIA).

• Surgical Innovation Associates (SIA) Announces Definitive Agreement to be Acquired by Integra LifeSciences

  12/1/2022

  Surgical Innovation Associates (SIA) today announced that it entered into a definitive agreement to be acquired by Integra LifeSciences Holding Corporation.

• Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase

  12/1/2022

  Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it entered into a definitive agreement to acquire Surgical Innovation Associates (SIA), which develops, markets and sells DuraSorb®, a resorbable synthetic matrix for plastic and reconstructive surgery.

• Integra LifeSciences Reports Third Quarter 2022 Financial Results

  10/26/2022

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the third quarter ending September 30, 2022.

• Integra LifeSciences to Host Third Quarter 2022 Financial Results Conference Call on October 26, 2022

  10/7/2022

  Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2022 financial results on Wednesday, October 26, 2022, prior to the market open.

• Integra LifeSciences Announces Key Executive Appointment - October 06, 2022

  10/6/2022

  Integra LifeSciences Holdings Corporation announced the appointment of Harvinder Singh as executive vice president and president of Integra’s international business.

• Integra LifeSciences Publishes Its Inaugural ESG Report

  9/29/2022

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, issued its inaugural Environmental, Social and Governance report.

• Integra LifeSciences Announces Participation in Upcoming Investor Conferences - Aug 23, 2022

  8/23/2022

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that it is participating in the following investor conferences:

• Integra LifeSciences Announces the Passing of Dr. Richard Caruso, Founder and Former Chairman and CEO

  8/16/2022

  Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that Dr. Richard Caruso, founder and former chairman and CEO of Integra LifeSciences passed away over the past weekend.

• Integra LifeSciences Reports Second Quarter 2022 Financial Results

  7/27/2022

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the second quarter ending June 30, 2022.

• Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022

  7/1/2022

  Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2022 financial results on Wednesday, July 27, 2022, prior to the market open.

• Integra LifeSciences Reports First Quarter 2022 Financial Results

  4/27/2022

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the first quarter ending March 31, 2022.

• Integra LifeSciences to Host First Quarter 2022 Financial Results Conference Call on April 27, 2022

  4/1/2022

  Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial results on Wednesday, April 27, 2022, prior to the market open. 

• Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance

  2/23/2022

  Integra LifeSciences Holdings Corporation reported financial results for the fourth quarter and full year ended December 31, 2021, consistent with its preliminary revenue results announced on January 11, 2022.

• Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase

  1/11/2022

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced certain unaudited preliminary fourth quarter and full-year 2021 revenue results.

• Integra LifeSciences Reports Third Quarter 2021 Financial Results

  11/2/2021

  Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the third quarter ending September 30, 2021.